Company news
Satellos Bioscience Inc (TSX:MSCL) news
Satellos Bioscience Inc news releases on 6ix. Latest, Jun 17, 2022: Satellos Bioscience Co-Founder and Chief Scientific Officer Awarded Prestigious Defeat…
Press releases — page 3
Satellos Bioscience Co-Founder and Chief Scientific Officer Awarded Prestigious Defeat Duchenne Canada 2022 Grant
June 17, 2022
Satellos Bioscience Inc. to Present at Bio International Convention 2022
June 14, 2022
Satellos Bioscience to Present at the LD Micro Invitational
June 1, 2022
Satellos Bioscience Inc. Announces First Quarter Financial Results and Operational Highlights
May 31, 2022
Satellos Bioscience Announces 2021 Year End Financial Results and Operational Highlights
April 29, 2022
Satellos Bioscience Inc. Invited to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
April 26, 2022
Satellos Bioscience Inc. to Present Game Changing Science at Upcoming European Molecular Biology Organization Workshop
April 21, 2022
Satellos Bioscience Inc.'s CSO to Present Game Changing Science During March 30th Drug Discovery News Webinar
March 29, 2022
Satellos Bioscience Provides Update on Novel Regenerative Drug Candidates
March 15, 2022
Satellos Bioscience Provides Update on Joint Development Initiative with NW PharmaTech Limited
March 11, 2022
Satellos Bioscience Inc. to Present Game Changing Science at Insights in Research Investor Summit and MDA Clinical & Scientific Conference 2022
March 10, 2022
Satellos Bioscience to Participate at BIO CEO & Investor Conference 2022
February 10, 2022
Satellos Bioscience Inc. Announces CEO Letter to Shareholders
January 24, 2022
Satellos Bioscience to Participate at Biotech Showcase(TM) Virtual 2022
January 6, 2022
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
December 20, 2021
Satellos Bioscience Inc. Announces Scientific Research Agreement with Université de Sherbrooke to Study Rare Muscular Dystrophies
December 16, 2021
Satellos Bioscience Announces New Board Appointments
December 6, 2021
Satellos Bioscience Reports Third Quarter 2021 Financial Results and Operational Highlights
November 29, 2021
Satellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations Services
October 27, 2021
Satellos Virtually Opens the Market
September 28, 2021
Satellos Bioscience Announces Appointment of J. Robert Hall as Vice-President, Finance and Administration
September 17, 2021
Satellos Bioscience Announces Evidence for Regeneration in Severe Model of Duchenne
September 13, 2021
Satellos Bioscience Announces Partnership with Jesse's Journey
September 7, 2021
Satellos Bioscience Announces Second Quarter 2021 Financial Results and MD&A
August 30, 2021
Satellos Bioscience Announces High Resolution Crystal Structure of Duchenne Drug Target
August 27, 2021
Satellos Bioscience Announces Joint Development Agreement with NW PharmaTech Limited for Oral CBD
August 18, 2021